Research ArticleInfectious Disease

Metal-captured inhibition of pre-mRNA processing activity by CPSF3 controls Cryptosporidium infection

See allHide authors and affiliations

Science Translational Medicine  06 Nov 2019:
Vol. 11, Issue 517, eaax7161
DOI: 10.1126/scitranslmed.aax7161

You are currently viewing the editor's summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Controlling Cryptosporidium

The apicomplexan parasite Cryptosporidium causes potentially life-threatening gastrointestinal symptoms, and treatment can be ineffective in vulnerable patient groups. Swale et al. show that a benzoxabarole, previously found to be effective against other apicomplexans, controlled cryptosporidiosis better than the standard of care in both neonatal and immunocompromised mouse models of infection. Biochemical assays and a cocrystal structure of the benzoxabarole bound to the active site of parasitic cleavage and polyadenylation specificity factor 3 (CPSF3) suggested that the selective targeting of Cryptosporidium by the benzoxabarole resulted from inhibition of parasitic pre-mRNA processing. This study proposes a potential treatment against cryptosporidiosis and provides insight into how oxabaroles inhibit apicomplexan parasites.

View Full Text